First Trust Advisors LP Takes Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
MarketBeat
First Trust Advisors LP purchased a new position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 263,137 shares of the company's stock, valued at approximately $3,665,000. First
NASDAQ:ARQT